Freddy A. Jimenez - Jun 3, 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP & GENERAL COUNSEL
Signature
/s/ Sam Martin, attorney-in-fact for Freddy A. Jimenez
Stock symbol
CLDX
Transactions as of
Jun 3, 2024
Transactions value $
-$185,900
Form type
4
Date filed
6/5/2024, 04:04 PM
Previous filing
Feb 15, 2024
Next filing
Jun 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDX Common Stock Options Exercise $83.1K +8.01K +30.88% $10.38 33.9K Jun 3, 2024 Direct
transaction CLDX Common Stock Sale -$269K -8.01K -23.6% $33.60 25.9K Jun 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (Right to Buy) Options Exercise $0 -8.01K -22.24% $0.00 28K Jun 3, 2024 Common Stock 8.01K $10.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.